Literature DB >> 24706294

Emotion recognition processing as early predictor of response to 8-week citalopram treatment in late-life depression.

Paulo R Shiroma1, Paul Thuras, Brian Johns, Kelvin O Lim.   

Abstract

BACKGROUND: In subjects with depression, exposure to antidepressants improves recognition of positive emotions. This phenomenon, which occurs early in the course of treatment, has been proposed as the initial step in the mechanism of action to subsequent therapeutic effects of antidepressants. To this date, it has not been well examined among older depressed patients.
METHOD: Older subjects with non-psychotic major depressive disorder were treated with citalopram in an 8-week open-label study. The main predictor of response and remission was the change in emotion recognition between baseline and day 7. Covariates included executive functions, baseline anxiety level, medical comorbidity, level of subjective stress, serum citalopram level, and level of social support.
RESULTS: Twenty-seven patients were considered for final analysis. Overall, accuracy of emotion recognition significantly improved between baseline (75%) and day 7 (83%) (X(2)  = 34.50, df = 1, p < 0.001). Improvement to identify happy expressions occurred at 25% and 50% intensity with ceiling effect at 0%, 75%, and 100%. Change in emotion processing was marginally significant in predicting antidepressant response at day 56. Multivariate analysis showed that emotion processing is a significant predictor of response and remission when considered along with perceived level of social support.
CONCLUSIONS: Recognition of mildly intense happy expression, which improved early in the course of citalopram treatment, predicts subsequent antidepressant response and remission when considered along with perception of social support. Further studies would be necessary to examine specific neural substrates in the affective network involved in the acute therapeutic action of antidepressant in late-life depression.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  citalopram; depression; emotions; old age; older adults

Mesh:

Substances:

Year:  2014        PMID: 24706294     DOI: 10.1002/gps.4104

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  12 in total

Review 1.  How do antidepressants work? New perspectives for refining future treatment approaches.

Authors:  Catherine J Harmer; Ronald S Duman; Philip J Cowen
Journal:  Lancet Psychiatry       Date:  2017-01-31       Impact factor: 27.083

2.  Brain structural correlates of alexithymia in patients with major depressive disorder

Authors:  Katharina Förster; Verena Enneking; Katharina Dohm; Ronny Redlich; Susanne Meinert; Adina Isabel ` Geisler; Elisabeth Johanna Leehr; Harald Kugel; Bernhard T. Baune; Volker Arolt; Pienie Zwitserlood; Dominik Grotegerd; Udo Dannlowski
Journal:  J Psychiatry Neurosci       Date:  2020-03-01       Impact factor: 6.186

3.  Depression severity is associated with impaired facial emotion processing in a large international sample.

Authors:  Lauren A Rutter; Eliza Passell; Luke Scheuer; Laura Germine
Journal:  J Affect Disord       Date:  2020-07-10       Impact factor: 4.839

Review 4.  A neurocognitive model for understanding treatment action in depression.

Authors:  Matthew B Warren; Abbie Pringle; Catherine J Harmer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-19       Impact factor: 6.237

Review 5.  The effects of drugs on human models of emotional processing: an account of antidepressant drug treatment.

Authors:  Abbie Pringle; Catherine J Harmer
Journal:  Dialogues Clin Neurosci       Date:  2015-12       Impact factor: 5.986

6.  Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.

Authors:  J B Stroud; T P Freeman; R Leech; C Hindocha; W Lawn; D J Nutt; H V Curran; R L Carhart-Harris
Journal:  Psychopharmacology (Berl)       Date:  2017-10-30       Impact factor: 4.530

7.  Selective serotonin reuptake inhibitor treatment retunes emotional valence in primate ventral striatum.

Authors:  Benjamin Pasquereau; Guillaume Drui; Yosuke Saga; Augustin Richard; Mathilde Millot; Elise Météreau; Véronique Sgambato; Philippe N Tobler; Léon Tremblay
Journal:  Neuropsychopharmacology       Date:  2021-03-10       Impact factor: 7.853

8.  A mechanistic account of serotonin's impact on mood.

Authors:  Jochen Michely; Eran Eldar; Ingrid M Martin; Raymond J Dolan
Journal:  Nat Commun       Date:  2020-05-11       Impact factor: 14.919

9.  Using Affective Cognition to Enhance Precision Psychiatry.

Authors:  Jack Cotter; Jennifer H Barnett
Journal:  Front Psychiatry       Date:  2018-06-29       Impact factor: 4.157

10.  Modulation of anterior cingulate cortex reward and penalty signalling in medication-naive young-adult subjects with depressive symptoms following acute dose lurasidone.

Authors:  Selina A Wolke; Mitul A Mehta; Owen O'Daly; Fernando Zelaya; Nada Zahreddine; Hanna Keren; Georgia O'Callaghan; Allan H Young; Ellen Leibenluft; Daniel S Pine; Argyris Stringaris
Journal:  Psychol Med       Date:  2019-01-04       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.